Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Summary
Bill A01522 amends the mental hygiene law to mandate the office of addiction services and supports to promote clinical research into the use of ibogaine as a treatment for addiction to heroin, methamphetamine, and cocaine. The bill aims to explore alternative treatment options for substance use disorders, particularly for individuals who have not found success with traditional methods. By facilitating research, the bill seeks to contribute to the growing body of evidence regarding the efficacy of ibogaine in addiction recovery.
Impact
If enacted, this bill would enhance the state's focus on innovative treatment methods for drug addiction, potentially leading to changes in how addiction services are delivered. It may also influence funding and resource allocation towards research initiatives that investigate ibogaine, potentially affecting existing treatment protocols and the overall approach to substance abuse in New York.
Sentiment
The sentiment surrounding Bill A01522 appears to be cautiously optimistic, with proponents advocating for the need to explore new treatment avenues in light of the ongoing addiction crisis. However, there may be concerns regarding the safety and regulatory implications of using ibogaine, which could lead to divided opinions among lawmakers and stakeholders in the addiction treatment community.
Contention
Notable points of contention include the safety and efficacy of ibogaine as a treatment option, with some advocates emphasizing its potential benefits while critics may raise concerns about its legality and the need for rigorous clinical trials. Stakeholders in the addiction treatment field may have differing views on whether resources should be directed towards researching ibogaine or improving existing treatment modalities.
Same As
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Requires the office of addiction services and supports to encourage, aid, and facilitate clinical research into the use of ibogaine in drug treatment for heroin, methamphetamine and cocaine addiction.
Requires the office of addiction services and supports to collect certain demographic data for incarcerated individuals in medication assisted treatment programs.
Requires the office of addiction services and supports to collect certain demographic data for incarcerated individuals in medication assisted treatment programs.
Requires rates paid for rehabilitation and opioid treatment be pursuant to certain fee schedules published by the office of addiction services and supports.
Requires rates paid for rehabilitation and opioid treatment be pursuant to certain fee schedules published by the office of addiction services and supports.
Requires the office of addiction services and supports and the office of mental health to publish information for calculation of rates paid for certain treatment pursuant to the medical assistance program in a form an manner prescribed by the commissioner of the office of addiction services and supports or the commissioner of mental health, as applicable.
Requires the office of addiction services and supports and the office of mental health to publish information for calculation of rates paid for certain treatment pursuant to the medical assistance program in a form an manner prescribed by the commissioner of the office of addiction services and supports or the commissioner of mental health, as applicable.
Establishes a research grant program to fund clinical trials of ibogaine for the treatment of veterans for post-traumatic stress disorder; creates a fund to provide monies for the research grant program.
Establishes an intensive addiction recovery and mental health integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and mental health integrated services to individuals with significant addiction and mental health issues who have had multiple and frequent treatment episodes.
Establishes an intensive addiction recovery and mental health integrated services pilot program to support two three-year demonstration programs that provide intensive addiction and mental health integrated services to individuals with significant addiction and mental health issues who have had multiple and frequent treatment episodes.